126 related articles for article (PubMed ID: 8214916)
1. Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration, and rheology of sputum.
Tomkiewicz RP; App EM; Zayas JG; Ramirez O; Church N; Boucher RC; Knowles MR; King M
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1002-7. PubMed ID: 8214916
[TBL] [Abstract][Full Text] [Related]
2. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.
App EM; King M; Helfesrieder R; Köhler D; Matthys H
Am Rev Respir Dis; 1990 Mar; 141(3):605-12. PubMed ID: 2310093
[TBL] [Abstract][Full Text] [Related]
3. [Pilot study of amiloride inhalation in children with cystic fibrosis].
Riedler J; Huttegger I
Klin Padiatr; 1992; 204(3):158-62. PubMed ID: 1614182
[TBL] [Abstract][Full Text] [Related]
4. Aerosolized amiloride: dose effect on nasal bioelectric properties, pharmacokinetics, and effect on sputum expectoration in patients with cystic fibrosis.
Hofmann T; Senier I; Bittner P; Hüls G; Schwandt HJ; Lindemann H
J Aerosol Med; 1997; 10(2):147-58. PubMed ID: 10168532
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
Knowles MR; Church NL; Waltner WE; Yankaskas JR; Gilligan P; King M; Edwards LJ; Helms RW; Boucher RC
N Engl J Med; 1990 Apr; 322(17):1189-94. PubMed ID: 2157983
[TBL] [Abstract][Full Text] [Related]
6. No added benefit from nebulized amiloride in patients with cystic fibrosis.
Graham A; Hasani A; Alton EW; Martin GP; Marriott C; Hodson ME; Clarke SW; Geddes DM
Eur Respir J; 1993 Oct; 6(9):1243-8. PubMed ID: 8287938
[TBL] [Abstract][Full Text] [Related]
7. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
King M; Dasgupta B; Tomkiewicz RP; Brown NE
Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
[TBL] [Abstract][Full Text] [Related]
8. [Elimination of secretions in CF patients under amiloride inhalation].
Lindemann H; Becker T; Bittner P; Boldt A; Hofmann T; Schwandt HJ
Pneumologie; 1990 Oct; 44(10):1148-50. PubMed ID: 2281055
[TBL] [Abstract][Full Text] [Related]
9. Mucus clearance and lung function in cystic fibrosis with hypertonic saline.
Donaldson SH; Bennett WD; Zeman KL; Knowles MR; Tarran R; Boucher RC
N Engl J Med; 2006 Jan; 354(3):241-50. PubMed ID: 16421365
[TBL] [Abstract][Full Text] [Related]
10. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.
Feng W; Garrett H; Speert DP; King M
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):710-4. PubMed ID: 9517580
[TBL] [Abstract][Full Text] [Related]
11. Revisited physicochemical and transport properties of respiratory mucus in genotyped cystic fibrosis patients.
Deneuville E; Perrot-Minot C; Pennaforte F; Roussey M; Zahm JM; Clavel C; Puchelle E; de Bentzmann S
Am J Respir Crit Care Med; 1997 Jul; 156(1):166-72. PubMed ID: 9230742
[TBL] [Abstract][Full Text] [Related]
12. Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea.
Wills PJ; Hall RL; Chan W; Cole PJ
J Clin Invest; 1997 Jan; 99(1):9-13. PubMed ID: 9011581
[TBL] [Abstract][Full Text] [Related]
13. [Amiloride inhalation therapy in mucoviscidosis].
Lindemann H
Monatsschr Kinderheilkd; 1993 May; 141(5):392-4. PubMed ID: 8326957
[TBL] [Abstract][Full Text] [Related]
14. Effect of uridine 5'-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis.
Bennett WD; Olivier KN; Zeman KL; Hohneker KW; Boucher RC; Knowles MR
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1796-801. PubMed ID: 8665037
[TBL] [Abstract][Full Text] [Related]
15. The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis.
Homnick DN; Marks JH; Rubin BK
J Aerosol Med; 2007; 20(1):45-9. PubMed ID: 17388752
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis.
Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE
Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317
[TBL] [Abstract][Full Text] [Related]
17. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches.
Puchelle E; de Bentzmann S; Zahm JM
Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436
[TBL] [Abstract][Full Text] [Related]
18. Aerosolized amiloride as treatment of cystic fibrosis lung disease: a pilot study.
Knowles MR; Church NL; Waltner WE; Yankaskas JR; Gilligan P; King M; Edwards LJ; Helms RW; Boucher RC
Adv Exp Med Biol; 1991; 290():119-28; discussion 129-32. PubMed ID: 1950741
[No Abstract] [Full Text] [Related]
19. Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis.
Daviskas E; Anderson SD; Jaques A; Charlton B
Chest; 2010 Apr; 137(4):861-8. PubMed ID: 19880909
[TBL] [Abstract][Full Text] [Related]
20. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium.
Middleton PG; Geddes DM; Alton EW
Eur Respir J; 1994 Nov; 7(11):2050-6. PubMed ID: 7875281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
